Latvia vs New Zealand: Coverage of the human papillomavirus vaccine
Latvia
54
in 2025
New Zealand
52
in 2025
Latvia rank
60th
New Zealand rank
61st
Coverage of the human papillomavirus vaccine over time
- Latvia
- New Zealand
How they compare
Latvia currently reports 54 against 52 in New Zealand, a difference of 2.
The two have swapped places 2 times across 12 shared years of data; in 2014 it was Latvia ahead.
Latvia ranks 60th and New Zealand ranks 61st of 85 countries.
New Zealand has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Latvia | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 47.33 | 56.17 | 8.83 | New Zealand |
| 2020s | 44.33 | 62.17 | 17.83 | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher coverage of the human papillomavirus vaccine, Latvia or New Zealand?
- Latvia, at 54 against 52 in New Zealand as of 2025.
- What is the difference in coverage of the human papillomavirus vaccine between Latvia and New Zealand?
- 2, with Latvia ahead.
- How many years of comparable data are there for Latvia and New Zealand?
- 12 years are reported by both, from 2014 to 2025.
- How do Latvia and New Zealand rank globally for coverage of the human papillomavirus vaccine?
- Latvia ranks 60th and New Zealand ranks 61st of 85 countries.
- Where does this data come from?
- Our World in Data, published as Coverage of the human papillomavirus vaccine. Statizoid refreshes it automatically from the source and publishes the full history for both places.